a year ago

4D Medicine Raises £3.4 Million for 3D-Printed Implants

  • 4D Medicine, a Nottingham-based startup developing biomaterials for 3D-printed implants and surgical devices, has raised £3.4 million in Series A funding led by Oshen Holdings

  • The funding will be used to complete pre-clinical testing of the company's first product range and seek FDA clearance for entry into the US orthopaedic market

  • 4D Medicine's biomaterial, 4Degra, is designed to gradually erode and be resorbed by normal metabolic processes as healing progresses, allowing natural tissue to grow back in its place

  • The company is also preparing to raise a Series B investment early next year.

      • ProblemHealthcare

      "Currently, many implants and surgical devices require secondary surgeries to remove them after healing, which can be painful and costly. Existing biomaterials are not ideal for use in all situations, and can lead to complications."

      Solution

      "4D Medicine has developed a novel biomaterial called 4Degra that is resorbable, meaning it gradually breaks down and is absorbed by the body as healing progresses. This eliminates the need for secondary surgeries and reduces the risk of complications. 4Degra can be used to create a range of 3D-printed implants and devices for use in orthopaedic surgery and other applications. "

      Covered on